May 8 (Reuters) - PAION AG PA8G.DE :
* PUBLISHES GROUP QUARTERLY STATEMENT FOR THE FIRST QUARTER
OF
2019
* CASH AND CASH EQUIVALENTS OF EUR 15.6 MILLION AS OF 31
MARCH
2019
* U.S. MARKET APPROVAL AND SUBSEQUENT LAUNCH OF REMIMAZOLAM
CAN BE
EXPECTED IN 2020
* IN Q1 OF 2019, NO REVENUES WERE REALIZED
* RESEARCH AND DEVELOPMENT EXPENSES AMOUNTED TO KEUR 3,063
IN Q1
OF 2019 (PRIOR-YEAR PERIOD: KEUR 3,360)
* NET LOSS FOR Q1 OF 2019 AMOUNTED TO KEUR 3,241 (NET LOSS
IN
PRIOR-YEAR PERIOD: KEUR 3,125).
* CONFIRMS ITS OUTLOOK FOR CURRENT FISCAL YEAR GIVEN IN
MARCH 2019
Source text for Eikon: ID:nEQ1yHqWMa
Further company coverage: PA8G.DE
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))